Skip to content

Post Intensive Care Syndrome in COVID19 Patients

Characterization and Management of Post Intensive Care Syndrome in COVID19 Patients.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04422444
Acronym
PICS-COVID19
Enrollment
150
Registered
2020-06-09
Start date
2020-06-01
Completion date
2022-06-01
Last updated
2023-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID19, Post Intensive Care Unit Syndrome

Brief summary

This project is based in the implementation of a combined monitoring system (technological solutions and medical visits) in survivors of the critical illness due to the infectious disease by COVID-19. The main objective of the project is to characterize the Post-Intensive Care Syndrome (PICS) and detect early needs for specific treatment.

Interventions

DIAGNOSTIC_TESTQuestionnaires

Participants will answer questionnaires in three areas: physical/functional, emotional status and cognitive status

Sponsors

Corporacion Parc Tauli
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years

Inclusion criteria

* Patients admitted to ICU for COVID 19

Exclusion criteria

* Mental health diagnosis previous to the COVID19 infection * Acquired brain damage or neurological disease previous to the COVID19 infection

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline Short Form 12 Health Survey (SF12) at 12 monthEvery month during a 12 months follow-up periodHealth related quality of live scale. Values are directly transformed in T scores (mean=50; SD=10), with higher scores meaning better outcome.

Secondary

MeasureTime frameDescription
Change from baseline Lawton & Brody Instrumental activities of daily living scale at 12 monthsEvery month during a 12 months follow-up periodMeasure of independent living skills. Values are from 0 to 8, with higher scores meaning better outcome.
Change from baseline Perceived Deficits Questionnaire (PDQ) at 12 monthsEvery month during a 12 months follow-up periodSelf-report measure of cognitive dysfunction. Values are from 0 to 22, with lower scores meaning better outcome.
Change from baseline Hospital Anxiety and Depression Scale (HADS) at 12 monthsEvery month during a 12 months follow-up periodA self-assessment instrument for detecting states of depression and anxiety in the setting of an hospital medical outpatient. Values are from 0 to 42, with lower scores meaning better outcome.
Change from baseline Davidson Trauma Scale (DTS) at 12 monthsEvery month during a 12 months follow-up period. Values are from 0 to 136, with lower scores meaning better outcome.Self-report measure of Post Traumatic Stress Disorder (PTSD) symptoms.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026